NextCure, Inc. (NXTC) Capital expenditures 2019–2025
NextCure, Inc. (NXTC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$474,000FY2025 · since FY2019: $3.1M → $474,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $474,000 | -42.2% |
| FY2024 | $820,000 | -61.2% |
| FY2023 | $2.1M | -10.3% |
| FY2022 | $2.4M | -66.9% |
| FY2021 | $7.1M | +111.6% |
| FY2020 | $3.4M | +10.1% |
| FY2019 | $3.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice